Details of the Drug Reposition

General Information of This Drug (ID: DMDMQW0)

Drug Name
SAR-100842   DMDMQW0
Synonyms LPA1/LPA3 antagonist (renal fibrosis), sanofi-aventis
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Systemic sclerosis DISF44L6 4A42 Phase 2 [1]
Fibrosis DIS6FM27 GA14-GC01 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT01651143) Proof of Biological Activity of SAR100842 in Systemic Sclerosis. U.S. National Institutes of Health.